Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lancellotti

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Revue Medicale De Liege|May 10, 2019
[Editorial The odyssey of interventional cardiology]P Lancellotti
Revue Medicale De Liege|December 31, 2010
[Medication of the month. Prasugrel (Efient): potent thienopyridine antiplatelet agent]P Lancellotti
Revue Medicale De Liege|November 3, 2012
[Medication of the month. Ticagrelor (Brilique): potent oral antagonist of platelet activity]P Lancellotti
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|December 21, 2010
[Aortic stenosis: development and predictive factors]P Lancellotti
Revue Medicale De Liege|June 26, 2008
[Ivabradine (Procoralan)]P Lancellotti
Revue Medicale De Liege|May 22, 2007
[Medication of the month. Olmesartan medoxomil hydroclorothiazide (Olmetec Plus or Belsar Plus]P Lancellotti
Revue Medicale De Liege|September 23, 2010
[Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet]P Lancellotti
Revue Medicale De Liege|May 10, 2019
[Arterial hypertension and renal denervation : fantasy or reality ?]C Martinez, P Lancellotti
Acta Cardiologica|July 17, 2023
Comments on association of HbA1c with carotid artery plaques in patients with coronary heart diseaseM Sprynger, P Lancellotti
Revue Medicale De Liege|December 7, 2010
[2010 European guidelines for antithrombotic therapy in patients with atrial fibrillation and new risk score for the assessment of the risk of bleeding]P Melon, P Lancellotti
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Revue Medicale De Liege|May 10, 2019
[Editorial The odyssey of interventional cardiology]P Lancellotti
Revue Medicale De Liege|December 31, 2010
[Medication of the month. Prasugrel (Efient): potent thienopyridine antiplatelet agent]P Lancellotti
Revue Medicale De Liege|November 3, 2012
[Medication of the month. Ticagrelor (Brilique): potent oral antagonist of platelet activity]P Lancellotti
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|December 21, 2010
[Aortic stenosis: development and predictive factors]P Lancellotti
Revue Medicale De Liege|June 26, 2008
[Ivabradine (Procoralan)]P Lancellotti
Revue Medicale De Liege|May 22, 2007
[Medication of the month. Olmesartan medoxomil hydroclorothiazide (Olmetec Plus or Belsar Plus]P Lancellotti
Revue Medicale De Liege|September 23, 2010
[Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet]P Lancellotti
Revue Medicale De Liege|May 10, 2019
[Arterial hypertension and renal denervation : fantasy or reality ?]C Martinez, P Lancellotti
Acta Cardiologica|July 17, 2023
Comments on association of HbA1c with carotid artery plaques in patients with coronary heart diseaseM Sprynger, P Lancellotti
Revue Medicale De Liege|December 7, 2010
[2010 European guidelines for antithrombotic therapy in patients with atrial fibrillation and new risk score for the assessment of the risk of bleeding]P Melon, P Lancellotti
Pageof 21